Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands
Feline lymphoma is currently less commonly associated with retrovirus infections as the feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). This is thought to have caused a shift in the distribution of anatomical subtypes and eventually have led to poorer treatment outcomes. The ai...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-08-01
|
| Series: | Animals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2615/13/16/2667 |
| _version_ | 1797585739982045184 |
|---|---|
| author | Hannah Versteegh Maurice M. J. M. Zandvliet Laurien R. Feenstra Francine E. M. M. van der Steen Erik Teske |
| author_facet | Hannah Versteegh Maurice M. J. M. Zandvliet Laurien R. Feenstra Francine E. M. M. van der Steen Erik Teske |
| author_sort | Hannah Versteegh |
| collection | DOAJ |
| description | Feline lymphoma is currently less commonly associated with retrovirus infections as the feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). This is thought to have caused a shift in the distribution of anatomical subtypes and eventually have led to poorer treatment outcomes. The aim of this study was to evaluate whether this change was also notable in the Netherlands, a country historically known for its low prevalence of FeLV and FIV, and to determine its consequences on treatment response. A 10-year cohort of 174 cats with large cell lymphoma (110 treated) were included and compared to historical data from previously published reports in the Netherlands. Of the 90 cats screened, only one tested positive for FeLV and three for FIV. The most current cohort had an increased age (median 8.7 years) and fever Siamese cats (6.3%) compared to previous reports, with alimentary (24.5%) and nasopharyngeal lymphoma (22.7%) being the most common subtypes. Sixty-six of the one hundred and ten cats (60%) went into complete remission, (CR) resulting in a median disease-free period (DFP) of 763 days, with nasopharyngeal and mediastinal having the longest DFP. The median overall survival time was 274 days with an estimated 1-year survival of 41.3% and a 2-year survival of 34.6%, respectively. Patient characteristics of cats with malignant lymphoma in the Netherlands have changed over the years, but this cannot be explained by differences in FeLV/FIV prevalence. Although the overall response rate to therapy did not change over time, for some lymphoma subtypes, longer DFPs were observed compared to 30 years ago. |
| first_indexed | 2024-03-11T00:11:18Z |
| format | Article |
| id | doaj.art-31b3d73e1bb540eb84974907bd438e56 |
| institution | Directory Open Access Journal |
| issn | 2076-2615 |
| language | English |
| last_indexed | 2024-03-11T00:11:18Z |
| publishDate | 2023-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Animals |
| spelling | doaj.art-31b3d73e1bb540eb84974907bd438e562023-11-18T23:58:25ZengMDPI AGAnimals2076-26152023-08-011316266710.3390/ani13162667Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The NetherlandsHannah Versteegh0Maurice M. J. M. Zandvliet1Laurien R. Feenstra2Francine E. M. M. van der Steen3Erik Teske4Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CS Utrecht, The NetherlandsDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CS Utrecht, The NetherlandsDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CS Utrecht, The NetherlandsDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CS Utrecht, The NetherlandsDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CS Utrecht, The NetherlandsFeline lymphoma is currently less commonly associated with retrovirus infections as the feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). This is thought to have caused a shift in the distribution of anatomical subtypes and eventually have led to poorer treatment outcomes. The aim of this study was to evaluate whether this change was also notable in the Netherlands, a country historically known for its low prevalence of FeLV and FIV, and to determine its consequences on treatment response. A 10-year cohort of 174 cats with large cell lymphoma (110 treated) were included and compared to historical data from previously published reports in the Netherlands. Of the 90 cats screened, only one tested positive for FeLV and three for FIV. The most current cohort had an increased age (median 8.7 years) and fever Siamese cats (6.3%) compared to previous reports, with alimentary (24.5%) and nasopharyngeal lymphoma (22.7%) being the most common subtypes. Sixty-six of the one hundred and ten cats (60%) went into complete remission, (CR) resulting in a median disease-free period (DFP) of 763 days, with nasopharyngeal and mediastinal having the longest DFP. The median overall survival time was 274 days with an estimated 1-year survival of 41.3% and a 2-year survival of 34.6%, respectively. Patient characteristics of cats with malignant lymphoma in the Netherlands have changed over the years, but this cannot be explained by differences in FeLV/FIV prevalence. Although the overall response rate to therapy did not change over time, for some lymphoma subtypes, longer DFPs were observed compared to 30 years ago.https://www.mdpi.com/2076-2615/13/16/2667felinelymphomaFeLV/FIVanatomical typeschemotherapy |
| spellingShingle | Hannah Versteegh Maurice M. J. M. Zandvliet Laurien R. Feenstra Francine E. M. M. van der Steen Erik Teske Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands Animals feline lymphoma FeLV/FIV anatomical types chemotherapy |
| title | Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands |
| title_full | Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands |
| title_fullStr | Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands |
| title_full_unstemmed | Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands |
| title_short | Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands |
| title_sort | feline lymphoma patient characteristics and response outcome of the cop protocol in cats with malignant lymphoma in the netherlands |
| topic | feline lymphoma FeLV/FIV anatomical types chemotherapy |
| url | https://www.mdpi.com/2076-2615/13/16/2667 |
| work_keys_str_mv | AT hannahversteegh felinelymphomapatientcharacteristicsandresponseoutcomeofthecopprotocolincatswithmalignantlymphomainthenetherlands AT mauricemjmzandvliet felinelymphomapatientcharacteristicsandresponseoutcomeofthecopprotocolincatswithmalignantlymphomainthenetherlands AT laurienrfeenstra felinelymphomapatientcharacteristicsandresponseoutcomeofthecopprotocolincatswithmalignantlymphomainthenetherlands AT francineemmvandersteen felinelymphomapatientcharacteristicsandresponseoutcomeofthecopprotocolincatswithmalignantlymphomainthenetherlands AT erikteske felinelymphomapatientcharacteristicsandresponseoutcomeofthecopprotocolincatswithmalignantlymphomainthenetherlands |